159 related articles for article (PubMed ID: 10334668)
1. Is there a role for adjuvant therapy in patients being treated with epoetin?
Hörl WH
Nephrol Dial Transplant; 1999; 14 Suppl 2():50-60. PubMed ID: 10334668
[TBL] [Abstract][Full Text] [Related]
2. Pharmacologic adjuvants to epoetin in the treatment of anemia in patients on hemodialysis.
Berns JS; Mosenkis A
Hemodial Int; 2005 Jan; 9(1):7-22. PubMed ID: 16191049
[TBL] [Abstract][Full Text] [Related]
3. [Guidelines for the treatment of anemia in chronic renal failure].
Triolo G;
G Ital Nefrol; 2003; 20 Suppl 24():S61-82. PubMed ID: 14666504
[TBL] [Abstract][Full Text] [Related]
4. EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update.
Bokemeyer C; Aapro MS; Courdi A; Foubert J; Link H; Osterborg A; Repetto L; Soubeyran P;
Eur J Cancer; 2007 Jan; 43(2):258-70. PubMed ID: 17182241
[TBL] [Abstract][Full Text] [Related]
5. [Erythropoietin-beta in the treatment of anemia in patients with chronic renal insufficiency].
Dimković N
Med Pregl; 2001; 54(5-6):235-40. PubMed ID: 11759218
[TBL] [Abstract][Full Text] [Related]
6. Meeting the challenges of a new millennium: optimizing the use of recombinant human erythropoietin.
Macdougall IC
Nephrol Dial Transplant; 1998; 13 Suppl 2():23-7. PubMed ID: 9566487
[TBL] [Abstract][Full Text] [Related]
7. Strategies for iron supplementation: oral versus intravenous.
Macdougall IC
Kidney Int Suppl; 1999 Mar; 69():S61-6. PubMed ID: 10084288
[TBL] [Abstract][Full Text] [Related]
8. How should anaemia be managed in pre-dialysis patients?
Levin A
Nephrol Dial Transplant; 1999; 14 Suppl 2():66-74. PubMed ID: 10334670
[TBL] [Abstract][Full Text] [Related]
9. Epoetin beta. A review of its pharmacological properties and clinical use in the management of anaemia associated with chronic renal failure.
Dunn CJ; Markham A
Drugs; 1996 Feb; 51(2):299-318. PubMed ID: 8808169
[TBL] [Abstract][Full Text] [Related]
10. Management of early renal anaemia: diagnostic work-up, iron therapy, epoetin therapy.
Van Wyck DB
Nephrol Dial Transplant; 2000; 15 Suppl 3():36-9. PubMed ID: 11032356
[TBL] [Abstract][Full Text] [Related]
11. Iron-replete hemodialysis patients do not require higher EPO dosages when converting from subcutaneous to intravenous administration: results of the Italian Study on Erythropoietin Converting (ISEC).
Pizzarelli F; David S; Sala P; Icardi A; Casani A
Am J Kidney Dis; 2006 Jun; 47(6):1027-35. PubMed ID: 16731298
[TBL] [Abstract][Full Text] [Related]
12. Epoetin alfa. A review of its clinical efficacy in the management of anaemia associated with renal failure and chronic disease and its use in surgical patients.
Dunn CJ; Wagstaff AJ
Drugs Aging; 1995 Aug; 7(2):131-56. PubMed ID: 7579784
[TBL] [Abstract][Full Text] [Related]
13. Ascorbic acid use in hyporesponders to Epoetin alfa.
Gibbs MA
Nephrol Nurs J; 2000 Aug; 27(4):413-5. PubMed ID: 11276634
[TBL] [Abstract][Full Text] [Related]
14. Safety aspects of parenteral iron in patients with end-stage renal disease.
Sunder-Plassmann G; Hörl WH
Drug Saf; 1997 Oct; 17(4):241-50. PubMed ID: 9352960
[TBL] [Abstract][Full Text] [Related]
15. [Frequency of anaemia and indications for treatment with epoetin in chronic renal failure at the pre-dialysis stage].
Jungers PY; Nguyen-Khoa T; Joly D; Choukroun G; Massy ZA; Jungers P
Presse Med; 2003 Feb; 32(5):212-6. PubMed ID: 12610461
[TBL] [Abstract][Full Text] [Related]
16. Novel aspects of vitamin C in epoetin response.
Tarng DC
J Chin Med Assoc; 2007 Sep; 70(9):357-60. PubMed ID: 17908648
[TBL] [Abstract][Full Text] [Related]
17. A study of the response of elderly patients with end-stage renal disease to epoetin alfa or beta.
Nicholas JC
Drugs Aging; 2004; 21(3):187-201. PubMed ID: 14979736
[TBL] [Abstract][Full Text] [Related]
18. The effect of i.v. iron alone or in combination with low-dose erythropoietin in the rapid correction of anemia of chronic renal failure in the predialysis period.
Silverberg DS; Blum M; Agbaria Z; Deutsch V; Irony M; Schwartz D; Baruch R; Yachnin T; Steinbruch S; Iaina A
Clin Nephrol; 2001 Mar; 55(3):212-9. PubMed ID: 11316241
[TBL] [Abstract][Full Text] [Related]
19. Should anaemia in subtypes of CRF patients be managed differently?
van Ypersele de Strihou C
Nephrol Dial Transplant; 1999; 14 Suppl 2():37-45. PubMed ID: 10334666
[TBL] [Abstract][Full Text] [Related]
20. [Iron supplementation during erythropoietin therapy in patients on hemodialysis].
Svára F; Sulková S; Kvasnićka J; Polakovic V
Vnitr Lek; 1996 Dec; 42(12):849-52. PubMed ID: 9072885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
